| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 07/08/2009 | EP2077112A1 Methods and compositions using thalidomide for the treatment and management of cancers and idiopathic pulmonary fibrosis |
| 07/08/2009 | EP2076261A2 Muscarinic receptor antagonists |
| 07/08/2009 | EP1685118B1 Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 07/08/2009 | EP1539933A4 Methods of organ regeneration |
| 07/08/2009 | EP1495022B1 Diazabicyclo alkane derivatives with nk1 antagonistic activity |
| 07/08/2009 | EP1383927B1 New polynucleotides and polypeptides of the erythropoietin gene |
| 07/08/2009 | EP1126826B9 Multiparticulate modified release composition of methylphenidate |
| 07/08/2009 | EP0738142B1 Perfluorocarbons as anti-inflammatory agents |
| 07/08/2009 | CN101475526A Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof |
| 07/08/2009 | CN100510073C Tryptase inhibitor |
| 07/08/2009 | CN100509811C Azaindoles |
| 07/08/2009 | CN100509810C Substituted beta-carbolines |
| 07/08/2009 | CN100509782C NK* antagonists |
| 07/08/2009 | CN100509773C Alpha -amino-n-hydroxy-acetamide derivatives |
| 07/08/2009 | CN100509758C Crystal of triterpene derivative |
| 07/08/2009 | CN100508978C Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 07/08/2009 | CN100508975C Use of pyrazolopyridine compound |
| 07/08/2009 | CN100508965C Dosage forms having prolonged active ingredient release |
| 07/07/2009 | US7557247 N-{2-[4-((R)-2-hydroxy-2-phenylethylamino)phenyl]ethyl}-(R)-2-hydroxy-2-(3-formamido-4-hydroxyphenyl)ethylamine monohydrochloride; pulmonary disease asthma or chronic obstructive pulmonary disease; administration by inhalation; salt formation, crystallization |
| 07/07/2009 | US7557210 Antiinflamamtory agents |
| 07/07/2009 | US7557128 Having antiallergic and anti-inflammatory effects while being devoid of the severe dose-limiting sedative side effects of ketotifen |
| 07/07/2009 | US7557117 4-oxoimidazolidine-2-spiropiperidine derivatives |
| 07/07/2009 | US7557106 inhibitors of FLT-3, Aurora-1, Aurora-2, and Aurora-3 protein kinases; leukemia; N-{4-[4-(5-Methyl-2H-pyrazol-3-ylmethyl)-6-(4-propyl-piperazin-1-yl)-pyrim- idin-2-ylsulfanyl]-phenyl}-propionamide |
| 07/07/2009 | US7557105 Proliferative disorders; cancer; 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide |
| 07/07/2009 | US7556957 Attenuated virus-like particle for use as gene transfer tool in treatment and prevention of metabolic disorders; tissue target therapy |
| 07/07/2009 | CA2486101C Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 07/07/2009 | CA2438324C Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 07/07/2009 | CA2406119C Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets |
| 07/02/2009 | WO2009082342A1 Steroid derivatives acting as glucocorticosteroid receptor agonists |
| 07/02/2009 | WO2009081789A1 Sulfonyl substituted 6-membered ring derivative |
| 07/02/2009 | WO2009081107A1 P-menthawe-3-carboxylic acid esters to treat airways diseases |
| 07/02/2009 | WO2009080199A1 4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof |
| 07/02/2009 | WO2009079911A1 Pegylated erythropoietin conjugate and preparation method and uses thereof |
| 07/02/2009 | WO2009079822A1 A bcg polysaccharide nucleic acid extractive and preparation method thereof |
| 07/02/2009 | WO2009046832A3 Short peptides used in medicine |
| 07/02/2009 | WO2009033762A3 Use of endothelin-3 as a therapeutic agent |
| 07/02/2009 | WO2009033739A3 Use of a peptide as a therapeutic agent |
| 07/02/2009 | WO2009033678A3 Use of a tuftsin as a therapeutic agent |
| 07/02/2009 | WO2009012375A3 Squarate kinase inhibitors |
| 07/02/2009 | WO2009010925A3 Annelated azaheterocyclic amides containing a pyrimidine fragment and method for the production and use thereof |
| 07/02/2009 | WO2007122581A3 Compositions and kits of phenylephrine |
| 07/02/2009 | US20090171086 2,4-pyrimidinediamine compounds and their uses |
| 07/02/2009 | US20090171085 N2,N4-bis(4-ethoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 07/02/2009 | US20090170941 Pharmaceutical Compounds |
| 07/02/2009 | US20090170917 Acid Mimic Compounds for the Inhibition of Isoprenyl-S-Cysteinyl Methyltransferase |
| 07/02/2009 | US20090170911 Novel azole compound |
| 07/02/2009 | US20090170903 Ester derivatives as phosphodiesterase inhibitors |
| 07/02/2009 | US20090170892 3-Hydroxy-6-phenylphenanthridines as pde4 inhibitors |
| 07/02/2009 | US20090170881 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170871 IL-8 Receptor Antagonists |
| 07/02/2009 | US20090170870 Amidine-containing compounds useful as muscarinic receptor antagonists |
| 07/02/2009 | US20090170853 4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent (hepatocellular cancer, colorectal cancer or non-small cell lung cancer) |
| 07/02/2009 | US20090170839 Aerosol formulation for inhalation containing an anticholinergic agent |
| 07/02/2009 | US20090170836 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170822 2-Methylene-20-Methyl-19,24,25,26,27-Pentanor-Vitamin D Analogs |
| 07/02/2009 | US20090170820 2-Methylene-(20S,25R)-19,26-Dinor-Vitamin D Analogs |
| 07/02/2009 | US20090170758 Compositions comprising pulmonary surfactants and a polymyxin having improved surface properties |
| 07/02/2009 | US20090170095 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM |
| 07/02/2009 | US20090169660 A composition of radix codonopsis and radix astragali, a method for preparation thereof and its application |
| 07/02/2009 | US20090169543 Method for regulating immune function in primates using the Foxp3 protein |
| 07/02/2009 | CA2707618A1 Steroid derivatives acting as glucocorticosteroid receptor agonists |
| 07/02/2009 | CA2707447A1 Sulfonyl-substituted 6-membered ring derivative |
| 07/01/2009 | EP2075252A1 Nk1 receptor antagonist composition |
| 07/01/2009 | EP2075000A1 Combination of azelastine and ciclesonide |
| 07/01/2009 | EP2074995A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 07/01/2009 | EP2074094A1 Sulfonamide derivatives as adrenergic agonists and muscarinic antagonists |
| 07/01/2009 | EP1713439B1 Pharmaceutical preparation for the oral cavity |
| 07/01/2009 | EP1697343B1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 07/01/2009 | EP1651230B1 Medicaments for inhalation comprising steroids and a novel fluorene carboxylic acid ester |
| 07/01/2009 | EP1537075B1 Diarylurea derivatives and their use as chloride channel blockers |
| 07/01/2009 | EP1527100B1 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 07/01/2009 | EP1471054B1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/01/2009 | EP1414428B1 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 07/01/2009 | EP1406858B1 Substituted 4-aminocyclohexanols |
| 07/01/2009 | EP1312675B1 Protein induced by homogeneous blood transfusion and dna encoding the same |
| 07/01/2009 | CN101468984A N-oxyde of n-phenyl-2-pyrimidine-amine derivatives |
| 07/01/2009 | CN101468029A Difructose anhydride-containing composition and use thereof |
| 07/01/2009 | CN100506831C Phosphonic acid compounds as inhibitors of serine proteases |
| 07/01/2009 | CN100506815C Piperidinyl targeting compounds that selectively bind integrins |
| 07/01/2009 | CN100506788C Arylalkylcarbamate derivatives production and use thereof in therapy |
| 07/01/2009 | CN100506776C NK1 antagonists |
| 07/01/2009 | CN100506277C Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 07/01/2009 | CN100506229C Piperidin-2,6-dione salts and its use in the treatment of stress-related affective disorders |
| 06/30/2009 | US7553971 Aryl aniline β2 adrenergic receptor agonists |
| 06/30/2009 | US7553939 Genes that encode cell surface molecules with conserved IgV and mucin domains; diagnosis or staging of cancer; treatment of an immunological disorder; detecting a predisposition to asthma |
| 06/30/2009 | US7553877 Use of 2-hydroxy-1,2,3,4,4a,9,10,10a-octahydrophenanthrene compounds glucocorticoid receptor agonists to treat certain inflammatory conditions such as arthritis, asthma |
| 06/30/2009 | US7553852 Caspase inhibitors and uses thereof |
| 06/30/2009 | US7553663 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 06/30/2009 | US7553660 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 06/30/2009 | US7553488 Chemokine inhibitors; for treatment of gout; for inhibiting migration of neutrophils involved in pathogenesis |
| 06/30/2009 | CA2527365C Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc |
| 06/30/2009 | CA2441096C Nicotinic receptor agonists for the treatment of inflammatory diseases |
| 06/25/2009 | WO2009079405A2 Assessing treatment compliance |
| 06/25/2009 | WO2009079392A1 Amidine-containing compounds useful as muscarinic receptor antagonists |
| 06/25/2009 | WO2009078798A1 Pharmaceutically acceptable salts of methyl (3-{ [[3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl] (3- morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy |
| 06/25/2009 | WO2009078782A1 Method and means for producing bronchorelaxation |
| 06/25/2009 | WO2009077371A1 Tetrazole-substituted arylamide derivatives and their use as p2x3 and/or p2x2/3 purinergic receptor antagonists |
| 06/25/2009 | WO2009077366A1 Triazole-substituted arylamide derivatives and their use as p2x3 and /or p2x2/3 purinergic receptor antagonists |
| 06/25/2009 | WO2009046875A3 Combination of splenopentin and thymopentin and the use thereof in medicine |
| 06/25/2009 | WO2009046863A3 Use of thymosin alpha 1 peptide or the combination with the human pancreatic polypeptide as a therapeutic agent |